Glycosylated hemoglobin

Promotive effect of comprehensive management on achieving blood glucose control in senile type 2 diabetics

S. - T. Yan, Li, C. - X., Li, C. - L., Li, J., Shao, Y. - H., Liu, Y., Zhong, W. - W., Fang, F. - S., Sun, B. - R., and Tian, H., Promotive effect of comprehensive management on achieving blood glucose control in senile type 2 diabetics, vol. 14, pp. 3062-3070, 2015.

The aim of this study was to evaluate the control of blood glucose and glycosylated hemoglobin A1c (HbA1c) and its influencing factors, in elderly type 2 diabetic mellitus (T2DM) patients undergoing comprehensive management. After years of comprehensive prevention of and control measures for diabetes, elderly T2DM patients who were receiving long-term health care were comprehensively evaluated through an annual physical examination. In addition to routine health examination, the patients were required to undergo HbA1c measurement.

Prognostic and assessment value of hyperglycemia and glycosylated hemoglobin in critical patients

Z. L. Zhang, Che, X. M., Bai, Z. H., Bu, W. J., Bai, L., and Pei, H. H., Prognostic and assessment value of hyperglycemia and glycosylated hemoglobin in critical patients, vol. 13, pp. 7006-7012, 2014.

Hyperglycemia is common in critical patients and high blood glucose levels have a negative effect on their prognosis. The aim of this study was to investigate the effect of hyperglycemia and glycosylated hemoglobin (GHb) in critical patients. A total of 648 critical patients were enrolled in the study and received a random blood glucose test when they entered the emergency department. If blood glucose was more than 11.1 mM, a GHb test was followed within 24 h. All patients were followed up for 28 days.

Subscribe to Glycosylated hemoglobin